Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
KNSA Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
30.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
28.10%
KNSA Stock Analysis
KNSA
PE Ratio:
52.6
KNSA
PEG Ratio:
1.1
KNSA
Forward EPS Growth (12 month):
46.50%
KNSA
PS Ratio:
4.8
KNSA
PSG Ratio:
0.2
KNSA
Forward Revenue Growth (12 month):
19.90%
KNSA Articles
No data was found